pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Sep 8·1 min read
save

Tech giants and health apps push users to link medical records for personalized services

Sep 8, 2026·read at Endpoints ↗Neutral

In the past six months, a wave of tech giants and digital‑health startups have begun urging users to connect their personal medical records through their mobile applications.

These companies argue that linking health data can power more personalized health insights, simplify access to care information, and enable new data‑driven features within their platforms.

At the same time, the push raises questions about privacy and data security as non‑clinical firms expand deeper into the health‑record ecosystem.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Why apps want your medical records”

read at Endpoints ↗
79 words · retrieved Sep 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 10h agoMerck reports mixed data for Lucentis competitor in diabetic macular edemaEndpoints
  • 11h agoAsahi Kasei lands approval for new HSV treatmentEndpoints
  • 13h agoMirum succeeds in rare liver disease trial; First Tracks delivers in celiacEndpoints
  • 13h agoBristol Myers reveals a pair of Phase 3 wins for fibrosis, RayzeBio drugsEndpoints
  • 13h agoBrent Saunders out as Bausch + Lomb CEO, an abrupt end to three-year runEndpoints